Fast_neutron_treatment_for_squamous_cell_carcinoma_of_the_head_and_neck:_final_report_of_Edinburgh_randomised_trial__OBJECTIVE--To_compare_neutron_treatment_and_megavoltage_(photon)_radiotherapy_in_locally_advanced_squamous_cell_carcinoma_of_the_head_and_neck._DESIGN--Randomised_trial_of_patients_stratified_by_site_of_primary_tumour_and_presence_or_absence_of_lymph_node_metastases._Follow_up_of_patients_after_treatment._SETTING--Department_of_clinical_oncology,_Western_General_Hospital,_Edinburgh._PATIENTS--165_Patients_with_untreated,_histologically_proved_squamous_cell_carcinoma_of_the_oral_cavity,_oropharynx,_larynx,_or_hypopharynx._All_patients_completed_treatment,_and_no_patient_was_lost_to_follow_up._INTERVENTION--Treatment_with_either_neutrons_or_photons._MAIN_OUTCOME_MEASURES--Disease_state_and_morbidity_(scored_with_the_system_of_the_European_Organisation_for_Research_on_Treatment_of_Cancer)_at_each_visit_during_follow_up._RESULTS--Of_the_165_patients,_85_were_randomised_to_receive_neutron_treatment_and_80_to_receive_photon_treatment._Minimum_follow_up_was_five_years._Local_control_of_cancer_remained_similar_in_the_two_groups,_being_achieved_in_37_(44%)_patients_after_neutron_treatment_and_36_(45%)_after_photon_treatment._Five_year_and_actuarial_10_year_survival_rates_were_24%_(20/85)_and_14%_respectively_in_the_group_treated_with_neutrons_and_34%_(27/80)_and_30%_respectively_in_the_group_treated_with_photons._Five_year_survival_rates_without_local_disease_were_19%_(16/85)_and_30%_(24/80)_respectively._Necrosis_was_more_common_after_neutron_treatment_than_after_photon_treatment._Seven_patients_in_the_neutron_group_who_developed_necrosis_died_whereas_no_deaths_were_associated_with_photon_treatment._CONCLUSION--Rates_of_long_term_local_control_were_similar_in_the_two_groups._Necrosis_related_to_radiation_was_more_common_in_patients_treated_with_neutrons,_and_the_mortality_related_to_treatment_was_significantly_higher_in_these_patients.